| Financial Year |
March 31 2023 |
| Monetary Funds |
2,194,797,253.76 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
625,947.00 |
| Accounts Receivable |
1,974,616,605.02 |
| Advances to Suppliers |
489,901,879.11 |
| Other Receivables |
301,437,114.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,980,251,961.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
188,347,474.39 |
| Total Current Assets |
7,617,364,309.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,028,120,591.90 |
| Under-construction Projects |
1,179,744,761.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
275,644,037.85 |
| R&D expenses |
26,075.48 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
11,738,767.65 |
| Other Non-Current Assets |
45,037,843.84 |
| Sub-Total of Non-Current Assets |
2,599,386,426.35 |
| Total Assets |
10,216,750,735.94 |
| Short-Term Loans |
299,326,411.59 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,073,949,721.44 |
| Accounts Payable |
676,423,045.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,494,625.55 |
| Taxes Payable |
19,629,549.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
74,783,974.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
75,455,245.85 |
| Other Current Liabilities |
28,060,309.58 |
| Sub-Total of Current Liabilities |
2,894,163,726.25 |
| Long-term Loans |
394,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
139,520,864.23 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,131,405.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
740,779,054.61 |
| Total Liabilities |
3,634,942,780.86 |
| Paid-In Capital(Or Share Stock) |
637,749,349.00 |
| Capital Surplus |
3,806,691,583.91 |
| Surplus Reserve |
90,579,859.48 |
| LESS:Treasury Stock |
843,000.00 |
| Undistributed Profits |
2,048,152,662.31 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,581,807,955.08 |
| Owner's Equity（Stockholder's Equity） |
6,581,807,955.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,216,750,735.94 |
